Austin · Pre-Seed–Series A · 9 people tracked
Also known as KDT VENTURES LLC
Find your way into KdT Ventures
2,693 people in our graph share verified history with the KdT Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
KdT invests at the earliest stages in frontier science, viewing science as the underlying 'source code' of reality. The firm backs founders who commercialize breakthroughs across biology, chemistry, physics, and computation, enabled by modern instrumentation, simulation, and AI that allow reading, interpreting, and redesigning the deepest layers of the physical world. It focuses on platform companies capable of engineering matter, energy, and information in new ways, spanning from atoms to bits. KdT also emphasizes long-term, deep relationships with portfolio companies and partners under its 'Venture for Science' approach.
Source: firm website, verified Sep 15, 2026.
Team · 9 people
from the firm's website & public directories
Founder mafia
3 people who came through KdT Ventures went on to found or lead other companies.
What they invest in
from 48 of 58 portfolio companiesBiotech ×37AI & Machine Learning ×18Healthtech ×15Deep Tech ×13Digital Health ×8Medical Devices ×8Climate Tech ×6New Materials ×6
HQs:United States×33Canada×1
Investments · 58 tracked
founders shown can be your intro pathBy year:2025 · 42024 · 42022 · 22021 · 62020 · 22019 · 119 dated
Azitra is a clinical-stage biopharmaceutical company developing genetically engineered bacteria and proteins for treating skin diseases through precision dermatology.
AI & Machine LearningBiotechHealthtechFarmington, US
Francisco D. Salva(President and Chief Executive Officer)inAzim Munivar(Executive Officer, Director, Promoter)
BoardStella Robertson(Director)inTravis Whitfill(Executive Officer, Director, Promoter)in
Board seatCain McClary· per SEC Form D
Co-investorsBios PartnersConnecticut InnovationsLeaps by Bayer
Faeth Therapeutics is a clinical-stage oncology company developing therapies that inhibit multiple nodes of the PI3K/AKT/mTOR (PAM) pathway.
BiotechHealthtechAustin, US
Anand Parikh(Executive Officer, Director, Promoter)inOliver Maddocks(Executive Officer, Director)inChristopher W. Gerry(President and General Counsel)
BoardAlex Morgan(Director)inJayson Dallas(Director)Robert Gould(Director)
Co-investorsAble PartnersAtacama VenturesCota CapitalFuture VenturesiSelect FundS2G Investments+6 more
Debut applies AI and biotechnology to discover and formulate cosmetic ingredients and beauty products, decoding skin and hair at the genomic level to create novel actives.
AI & Machine LearningBiotechConsumerSan Diego, US
Joshua Britton(Founder)in
Co-investorsGS FuturesMaterial ImpactBreakout VenturesSandbox IndustriesACVC PartnersBetter Ventures Central Llc+8 more
.png)
Solugen develops a biomanufacturing platform using fermentation and bioprocessing technology to produce specialty chemicals at scale.
Advanced ManufacturingBiotechCleantechClimate TechHealthtechHouston, US
Sean Hunt(Founder/CTO)inGaurab Chakrabarti(Founder)in
BoardSeth Bannon(Director)in
Co-investorsFifty YearsFounders FundLowercarbon CapitalY CombinatorBaillie GiffordGIC+22 more
Andes develops a microbial technology that converts atmospheric carbon dioxide into stable soil inorganic carbon, enabling agricultural fields to generate verified carbon credits for emissions reductions.
AgTechCleantechClimate TechImpact & Social GoodAlameda, US
Board seatPhil Grayeski· per SEC Form D
Co-investorsCavallo VenturesLeaps by BayerVoyager Partners
Checkerspot uses microalgae precision fermentation to produce specialized lipids and fats, including a bio-equivalent source of the sn-2 palmitate fat found in mother's milk, rare bioactive fatty acids, and tropical fat alternatives.
BiotechClimate TechFoodTechNew MaterialsAlameda, US
Scott Franklin(Executive Officer, Director)inCharles Dimmler(Executive Officer, Director)inJohn Krzywicki(CEO)inLayla Ward(CFO)inCasey Lippmeier(CTO)inLeon Parker(SVP, Molecular Biology)in
Board seatAndrew Cain McClaryCain McClary· per SEC Form D
Co-investorsBaruch Future VenturesBreakout VenturesCavallo VenturesBuilders VCRefactor Capital
Particella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company developing an oral lipid nanoparticle platform to deliver nucleic acids, such as mRNA, to the intestinal epithelium.
BiotechDeep TechSan Francisco, US
Mubhij Ahmad(Executive Officer, Director)David Rabuka(Director)Timothy Paul Day(Director)
BoardDrew Lanza(Director)in
Board seatAndrew Cain McClary· per SEC Form D · $8.9M raise · filed Apr 2022
Co-investorsBerkeley CatalystBlue Bear Ventures
Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.
BiotechDeep TechSan Carlos, US
Matthew Hill(Executive Officer, Director)in
BoardPeter Zhou(Director)inJonathan Sheena(Director)in
Board seatCain McClary· per SEC Form D
Co-investorsACVC PartnersAndreessen HorowitzRaptor GroupTriatomic CapitalAME Cloud VenturesDigitalis Ventures+1 more
Transcera is a biotech company developing a new class of therapeutics that use lipid trafficking pathways to direct extracellular proteins into lysosomes for degradation, aimed at treating chronic diseases.
BiotechDeep TechBoston, US
Wayne Lencer(Co-Founder & SAB Chair)Hunter Goble(Co-Founder & CEO)inJustin Wolfe(Co-Founder & CSO)in
Board seatPhil Grayeski· per SEC Form D
Co-investorsPortal InnovationsTau VenturesDigitalis VenturesPear VCTAU VenturesXora Innovation Pte Ltd
STRM.BIO develops technology to deliver gene therapies, aiming to improve how these treatments reach patients.
BiotechDeep TechHealthtechLongevityMedical Devices
Michael Luther(CEO)in
Co-investorsAscension VenturesBreakout LabsBreakout VenturesDelos CapitalNYBC Ventures
Abridge builds AI software that converts clinical conversations into structured insights for healthcare providers.
AI & Machine LearningDigital HealthHealthtechPhiladelphia, US
Shiv Rao(Founder & CEO)inShiv (Shivdev) Rao(Founder)inJulia Chapin(Executive Officer)Sagar Sanghvi(Executive Officer)in
BoardAndy Weissman(Director)inSebastian Duesterhoeft(Director)in
Co-investorsAlpha Square Groupalphabet angelsAndreessen HorowitzBessemer Venture PartnersCapitalGCatalio Capital Management, LP+21 more
Andes is a mission-driven company focused on protecting the planet and applying technology in a nature-related context.
AgTechBiotechClimate Tech
Co-investorsCapria VenturesCavallo VenturesGermin8 VenturesSunna VenturesVoyager PartnersYamaha Motor Ventures+3 more
Aperiam Bio uses computer-vision algorithms to identify "hyperfolding" protein variants with improved expression, solubility, and stability, aiming for order-of-magnitude gains in protein performance.
AI & Machine LearningBiotechDeep TechAustin, US
Austin Cole(CEO & Founder)Guillaume Cottarel(Head of Program)inRussell Durrett(Chief Business Officer)
Co-investorsCivilization Ventures Management, LlcOMX VenturesAxial VC
Braid Health combines AI imaging copilots with board-certified radiologists to provide second opinions on MRI, CT, and ultrasound scans, along with AI-generated explanations and workflow tools.
AI & Machine LearningDigital HealthHealthtech
Kevin Quennesson(Founder)in
Co-investorsBronze InvestmentsJazzya InvestmentsLux CapitalMyelin VC
Canaery develops a nose-computer interface that combines animal olfaction with neurotechnology and AI to detect substances and diagnose diseases.
AI & Machine LearningBiotechDeep TechHardwareMedical Devices
Gabriel(Chief Executive Officer)Peter(Chief Technology Officer)
BoardDmitry(Chief Science Advisor)
Co-investors15th RockGood News VenturesBreakout VenturesDolby Family Ventures
Cavallo Ventures is the venture capital arm of Wilbur-Ellis, investing in innovative technology companies across agriculture, specialty chemicals, and animal nutrition sectors.
AgTechEnterprise Software
Michael Wilbur(President)in
Co-investorsWilbur-Ellis [Cavallo]Accelr8Builders VCCavallo VenturesLeaps by Bayer
Character Bio is a patient-driven therapeutics company that combines genomics, longitudinal clinical and imaging data, and machine learning to identify genetic drivers of disease progression and develop new treatments, with a focus on polygenic diseases.
AI & Machine LearningBiotechDigital HealthJersey City, US
Cheng Zhang(CEO, Co-Founder)inMarcel van der Brug(Scientific Advisor, Co-Founder)inNick Johnson(Technology Advisor, Co-Founder)inDaniel Elgort(Chief Data and Analytics Officer)inLaura Carter(Chief Scientific Officer)inRobert Kim(Chief Medical Officer)in
Co-investorsaMoonSanofi VenturesInnovation EndeavorsLuma GroupCantos VenturesCatalio Capital Management, LP+3 more
Creasallis develops CreaTap, a patented "plug-and-play" antibody modification technology that improves the penetration of antibody-based drugs into solid tumours, applicable to monoclonal, bispecific, and antibody-drug conjugates.
Biotech
Zahra Jawad(Founder)in
Co-investorsBlueYard CapitalPace VenturesZAKA VC
Dimension Bio is a biotechnology company that designs and manufactures regenerative therapeutics using its BioNidum™ platform to restore tissue function lost to disease, trauma, or aging.
BiotechHealthtechNew MaterialsChicago, US
Caralynn Nowinski Collens, M.D.(Co-founder & CEO)inRamille Shah, Ph.D.(Co-founder & CSO)Ramille Shah(Director)Caralynn Collens(Executive Officer, Director)inAdam Jakus(Executive Officer, Director)in
BoardRima Chakrabarti(Director)in
Co-investorsBetter Ventures Central LlcLofty VenturesPathway BioventuresPortal InnovationsSolas BioVenturesPrime Movers Lab
Dyno Therapeutics develops artificial intelligence-powered genetic technologies for gene therapy, specifically engineering adeno-associated virus (AAV) capsids to improve gene delivery for treating genetic diseases.
AI & Machine LearningBiotechWatertown, US
Eric Kelsic(CEO & Cofounder)inSam Sinai(Vice President, Head of ML & Cofounder)inAdrian Veres(Chief Scientific Officer & Cofounder)inGeorge Church(Scientific Cofounder, SAB)inTomas Bjorklund(Scientific Co-founder, SAB)inAlan Crane(Executive Chairman & Cofounder, Polaris Entrepreneur Partner)
Co-investorsAndreessen HorowitzCRV (Charles River Ventures)GENERAL INCEPTIONGV (Google Ventures)Lux CapitalObvious Ventures+2 more
Elo develops plant-based food ingredients and technologies to enhance nutritional value, taste, and climate resilience in everyday foods.
AgTechBiotechClimate TechFoodTechNew MaterialsDurham, US
ToddMichele Fite(Executive Officer)inMatthew Todd Rands(Executive Officer, Director)Chloe Pavely(Executive Officer)inMatt DiLeo(Director)inPaul Boyer(Executive Officer)in
Co-investorsDCVC (Data Collective)Accelr8DCVC BioNovo Holdings
Epana Bio develops therapies for autoimmune diseases by leveraging genomics and AI to identify and target cellular origins of disease, with a focus on precision medicine for patient populations.
AI & Machine LearningBiotechDigital Health
Co-investorsBreakout LabsBreakout VenturesHAWKTAILHummingbird VenturesOMX VenturesRefactor Capital
Equii makes food products that combine complete protein with carbohydrates while reducing sugar, positioned around balanced nutrition.
ConsumerFoodTechWellness & Fitness
Monica Bhatia(Founder)in
Co-investorsAurum Venture PartnersVU Venture PartnersWestern Technology Investment
Index Biosystems builds an AI platform for food safety and quality assurance (FSQA) teams in food manufacturing, combining AI agents that automate investigations and audit prep with BioTags — food-grade, DNA-labeled microbial tracers that generate molecular data for tracing material movement and validating sanitation.
AI & Machine LearningBiotechFoodTechToronto, CA
Co-investorsUndeterred CapitalVanedge CapitalVanedge Capital Limited Partnership
MacroCycle uses a proprietary chemical process called SolvoGenesis, based on solvent systems and macrocyclic chemistry, to convert textile waste into pure polyester resin at low cost.
Circular EconomyCleantechNew MaterialsCambridge, US
Stwart Peña Feliz(Executive Officer, Director)inJan-Georg Rosenboom(Executive Officer, Director)in
BoardCatia Cesari(Director)Temple Fennell(Director)in
Co-investorsCircular Innovation FundNeotribe VenturesVolta CircleClean Energy VentureClean Energy VenturesCycle Capital
March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments.
BiotechMedical DevicesHouston, US
Sarah Hein(CEO, Co-Founder)inMaksim Mamonkin(Co-Founder, Chair Scientific Advisory Board)Malcolm Brenner(Co-founder)
BoardThomas Luby(Director)inPeter Olagunju(Director)inJoseph Petrosino(Director)
Co-investorsMission Biocapital4BIO CapitalCancer FundFitz Gate VenturesModi VenturesPortal Innovations+1 more
Marigold Health operates an anonymous online community and app where people facing mental health or substance use challenges support each other, with some members receiving one-on-one help from certified Peer Recovery Coaches.
AI & Machine LearningDigital HealthMental Health
Shrenik Jain(Founder)in
Co-investorsBantam GroupDorm RoomEpsilon Health InvestorsFlare Capital PartnersStand Together Ventures LabTamarisc Ventures+4 more
Molecule operates a blockchain-based platform supporting decentralized science (DeSci), funding research projects and connecting scientists and entrepreneurs.
AI & Machine LearningBiotechCrypto & Web3
Paul Kohlhaas(Founder)in
Co-investorsBackedCompoundFifty YearsInflection.xyzLunar VenturesShine Capital+6 more
Montara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's.
AI & Machine LearningBiotechDeep TechSan Francisco, US
Kevan Shokat(Co-Scientific Founder & Chairman of the SAB)Thomas Südhof(Co-Scientific Founder & SAB Member)Seth Stratton(Director)Dirk Langdorf(Director)Nicholas Hertz(Executive Officer, Director)
Co-investorsTwo Bear CapitalDementia Discovery FundDolby Family Ventures
Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.
BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US
Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)in
BoardJacob Robinson(Co-founder & CEO)in
Co-investorsArboretum VenturesPsyMed VenturesTMC Venture FundXEIA Venture PartnersCapital FactoryDivergent Capital+3 more
Nosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development.
AI & Machine LearningBiotechDeep TechMedical Devices
Seth Myers(Founder)in
Co-investorsAlleyCorpMadrona Venture GroupAlley Robotics Ventures
Onc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making.
AI & Machine LearningBiotechDigital Health
Akshay Nanduri(Founder)in
Co-investorsLifeX VenturesDigitalis Ventures
AI-powered pathology for improved patient outcomes
Boston, US
ANDREW BECK(Executive Officer, Director)inADITYA KHOSLA(Executive Officer, Director)
BoardMICHELLE DIPP(Director)STANLEY LAPIDUS(Director)inJEFF LEIDEN(Director)
Co-investors8VCBIOSPRING PARTNERSFairhaven Capital PartnersGeneral CatalystNimble PartnersOrbiMed+2 more
.png)
Perceptive applies AI and robotics technology to dental practice, helping dentists increase patient capacity.
AI & Machine LearningHealthtechMedical DevicesRoboticsBoston, US
Chris Ciriello(Founder)inScott Phillips(Founder)inPhil Getto(CTO)inAlex Furleigh(Chief of Staff)in
Co-investorsAngel Physicians FundDIANecessary VenturesTSVCY Combinator
PHNX Materials refines industrial waste and byproduct streams into critical metals such as gallium, germanium, and silicon, along with products for the building materials and agriculture industries.
Circular EconomyCleantechNew Materials
Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer.
BiotechHealthtechLongevitySan Diego, US
Noah Davidsohn(CSO, Co-Founder)inDaniel Oliver(CEO, Co-Founder)inGeorge Church(Co-Founder and SAB)Deborah Ascheim(Chief Medical Officer)in
Co-investorsCompanion FundConnecticut InnovationsDigitalis VenturesKendall Capital Partners
Reverb Therapeutics develops immunotherapies built on its Amplify•R platform, which modulates the body's natural immune system using targeted molecules such as IL-15-directed compounds.
BiotechHealthtech
Co-investorsInBC Investment Corp.Thin Air Labs
BiotechWaltham, US
Ellen E. Sheets(Executive Officer, Director)in
BoardCarl M. Berke(Director)inNancy Hong(Director)in
Co-investorsBold Capital PartnersDigitalis VenturesRiverVest Venture Partners
Skeletalis is developing OASIS, a targeted small-molecule platform for musculoskeletal and bone health that concentrates therapy at sites of active bone loss while preserving the body's natural bone remodeling.
BiotechDeep TechHealthtech
Syenex provides cell delivery technologies and contract development services for therapeutic cell engineering, serving biopharmaceutical companies developing cell-based therapies.
BiotechDeep TechMedical DevicesEvanston, US
John D. Rosanelli(Executive Officer, Director)
Co-investorsAlleyCorpAlley Robotics Ventures
Tacit Therapeutics develops RNA-based gene therapy approaches by redirecting cellular splicing processes to repair mutated genes.
BiotechDeep TechHealthtechSan Francisco, US
Co-investorsEisai Innovation, Inc.Mitsui Global Investment
Durham, US
Kris Wood(Director)Eoin McDonnell(Executive Officer, Director)
Co-investorsAlexandria
Terray is a drug discovery company that combines proprietary hardware, large-scale experimental datasets, and AI through its EMMI platform to design small molecule medicines.
AI & Machine LearningBiotechDeep Tech
Eli Berlin(Founder)in
BoardChris PicardoinDusan PerovicinSid ShenaiinSamuel BjorkinBassil Dahiyat, Ph.D.
Co-investorsDeviation CapitalDigitalis VenturesMadrona Venture GroupSummit Peak InvestmentsMana VenturesNVentures+1 more
Theator builds an intelligence layer for surgery that turns video from minimally invasive procedures into usable data.
AI & Machine LearningDigital HealthHealthtechMedical DevicesPalo Alto, US
Dotan Asslemann(Director)Tamir Wolf(Executive Officer, Director)inDotan Asselmann(Founder)in
BoardGigi Levy Weiss(Director)in
Co-investorsBlumberg CapitalInsight PartnersNFXStageOne Ventures
Tierra Biosciences develops high-performance protein design technology, serving biotechnology and pharmaceutical industries.
Biotech
Co-investorsBeresford VenturesCreative VenturesFifty YearsFREEFLOWMaterial ImpactHumboldt+1 more
ZymoChem develops bio-based materials using proprietary Carbon Conserving (C2) microbes that convert renewable feedstocks into high-value materials with increased yields.
BiotechCircular EconomyClimate TechNew MaterialsSan Leandro, US
Harshal Chokhawala(Founder & CEO)in
Co-investorsAccelr8Breakout LabsBreakout VenturesCavallo VenturesDudley FundFreshTracks Capital+7 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Debut BiotechnologyCircularisbiotechCypris MaterialsElementalmachinesHifidelitygeneticsModulus TherapeuticsModulustherapeuticsParthenontxPhotomedicsTavrostxXilis
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 3
IPOs and acquisitions across the tracked portfolioAzitraNYSE: AZTRFaeth TherapeuticsNASDAQ: FTHModulus Therapeuticsacq. by Ginkgo Bioworks
Portfolio news
latest coverage across their companies
Rejuvenate Bio · intelligence360.news · Jul 30, 2026
Azitra · aol.com · Jul 15, 2026
Montara Therapeutics · convention.bio.org · Jun 23, 2026
Braid Health · radiologybusiness.com · May 18, 2026
Exthymic · nasdaqprivatemarket.com · Apr 3, 2026
Solugen · agfundernews.com · Mar 19, 2026
Andes Ag · agropages.com · Feb 11, 2026
Frequently asked questions
- What stage does KdT Ventures invest at?
- KdT Ventures invests at the Pre-Seed, Seed, Series A stages.
- What is KdT Ventures's typical check size?
- KdT Ventures typically writes checks of $500K – $3M.
- What sectors does KdT Ventures focus on?
- KdT Ventures focuses on AI & Machine Learning, Biotech, Climate Tech, Deep Tech, New Materials.
- Where is KdT Ventures located?
- KdT Ventures is headquartered in Austin, US.
- Does KdT Ventures lead rounds?
- KdT Ventures typically participates in rounds rather than leading them.
Media · Podcasts & interviews
featuring the teamVentures #3 w/ Phil Grayeski - Partner @ KdT Ventures | BIOS
BIOS · Phil Grayeski
Building Relationships in Pharma 😊 w/ Cain McClary - Founder & Managing Partner @ KdT Ventures
BIOS · Cain McClary
Leaders on a Mission - Cain McClary, Founder& Managing Partner, KdT Ventures, Episode 35
Leaders on a Mission · Cain McClary
Images
Co-investors · 7
Madrona Venture Group is a Seattle-founded venture firm that partners with founders across early and acceleration stages, providing capital plus hands-on support in recruiting, strategy, business development, and fundraising.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
Builders VC is a venture firm run by operators and investors that backs founders solving complex, mission-critical problems in industries dominated by legacy systems.
Lifeforce Capital is a venture firm investing in software companies transforming large healthcare markets.
Mayfield is a venture capital firm that invests in early-stage consumer and marketplace companies, backing founders from inception through IPO.
Industry Ventures is an investment firm founded in 2000 that provides flexible capital solutions across the venture life cycle, from seed and early-stage investing to late-stage secondaries and tech buyouts of VC-backed companies.
Firms observed investing alongside KdT Ventures, from public investor directories. Shared companies are the overlap with KdT Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Fly Ventures is an early-stage venture firm that backs founders at the zero-to-one stage, with portfolio companies going on to raise substantial follow-on funding from top US and European VCs.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Playground Global is a venture capital firm that invests in deep tech companies built by scientists and engineers, spanning next-generation compute, automation, energy, and computational biology.